About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Florida | 1,129 Studies

Clinical Trials Lung CancerFlorida

Lung Cancer Clinical Trials in Florida

Find 1,129 clinical trials for lung cancer near Florida. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Florida

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 1,129 trials

RecruitingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformThis study is being done to collect tissue samples to test how accurately a tumor response platform, Elephas, can predict clinical response across multiple types of…NCT06349642·Phoenix, Arizona and 2 others TerminatedRadiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)This study is to determine if Stage III NSCLC patients treated with ipilimumab with thoracic radiation therapy followed by nivolumab monotherapy every 4 weeks for up to 12 months…NCT03663166·Tampa, Florida and 2 others CompletedA Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung CancerTo determine the efficacy of ABT-751 when administered in combination with standard pemetrexed in subjects with advanced or metastatic NSCLC.NCT00297089·Fayetteville, Arkansas and 47 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLCThis study is for patients with advanced/metastatic non-small cells lung cancer (NSCLC) who have not received any treatment through the vein for the advanced disease.NCT06246110·Daphne, Alabama and 37 others

RecruitingA Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Researchers want to learn if MK-1084, the study medicine, can treat advanced or metastatic non-squamous NSCLC.NCT07286149·Clermont, Florida and 27 others

CompletedPhase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract CancersThe main purpose of the study is to: * Determine the safety and tolerability of erlotinib and LBH589B.NCT00738751·Tampa, Florida

CompletedStudy of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerThe primary purpose of this clinical research study is to learn if patients treated with the combination of Taxane/Carboplatin plus Cetuximab (C/T/C) have a longer…NCT00112294·Birmingham, Alabama and 123 others

TerminatedM7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)The main purpose of this study was to evaluate safety and efficacy in participants treated with concomitant chemoradiation therapy (cCRT) plus M7824 followed by M7824 compared to…NCT03840902·Orange, California and 103 others

RecruitingStudy to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC PatientsTNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic activity of oral TNG462 in…NCT06922591·Scottsdale, Arizona and 17 others

CompletedCisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00017459·Los Angeles, California and 41 others

CompletedA Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based ChemotherapyThe purpose of the study is to compare the survival of participants who receive chemotherapy and ramucirumab versus chemotherapy alone as second line treatment for NSCLC after…NCT01168973·Phoenix, Arizona and 230 others

Active not recruitingStudy of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) MutationsThis is a Phase 1b, open-label, multi-center, dose-escalation and dose expansion study designed to evaluate the safety, pharmacokinetics (PK), and preliminary antitumor activity…NCT05364073·Prescott, Arizona and 41 others

RecruitingA Study of IDP-001 in Advanced or Metastatic Solid TumorsThis clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic…NCT07602842·Los Angeles, California and 5 others

RecruitingAnalysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred CentersThe study is a retrospective observational study.NCT06626243·Miami, Florida and 5 others

Active not recruitingStudy of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerThis study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best suited for telisotuzumab vedotin therapy in the…NCT03539536·Mobile, Alabama and 251 others

RecruitingA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLCThe purpose of ARTEMIDE-Lung03 is to evaluate the efficacy and safety of rilvegostomig compared to pembrolizumab, both in combination with platinum-based doublet chemotherapy, as…NCT06627647·Mobile, Alabama and 299 others

RecruitingA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPhase I Study of NT-175, an autologous T cell therapy product genetically engineered to express an HLA-A\*02:01-restricted T cell receptor (TCR), targeting TP53 R175H mutant…NCT05877599·Gilbert, Arizona and 22 others

TerminatedTIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed TherapyThe purpose of this study is to compare the safety and anti-tumor effect of rociletinib with erlotinib in patients whose tumors have specific EGFR mutations and who have not…NCT02186301·Birmingham, Alabama and 73 others

UnknownA Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549This dose-escalation study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of IPI-549 monotherapy and IPI-549 in combination with nivolumab in…NCT02637531·San Diego, California and 10 others

RecruitingPersonalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual DiseaseThis is a phase 1 clinical trial to evaluate the safety, feasibility and immunogenicity of a personalized cancer vaccine strategy in patients with solid tumors and molecular…NCT06529822·Orlando, Florida and 2 others

PreviousPage 11 of 57Next

Other Conditions in Florida

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma